Literature DB >> 16783840

3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents.

Laura De Luca1, Rosaria Gitto, Maria Letizia Barreca, Roberta Caruso, Silvana Quartarone, Rita Citraro, Giovambattista De Sarro, Alba Chimirri.   

Abstract

A 3D pharmacophore model predicting anticonvulsant activity was obtained for a series of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives recently disclosed as a new class of noncompetitive AMPA receptor antagonists. The training set included 17 compounds with varying potency against audiogenic seizures in DBA/2 mice. The best statistical hypothesis, generated with the HypoGen module of Catalyst 4.9, consisted of five features: two hydrogen bond acceptors, two hydrophobic features, and one hydrophobic aromatic region, providing a model with a correlation coefficient of 0.919. The obtained model was an efficient tool in the design of some new anticonvulsant agents containing the tetrahydroisoquinoline scaffold. Moreover, in order to explain the different degree of efficacy of the newly designed N-substituted derivatives, excluded volumes were also considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783840     DOI: 10.1002/ardp.200600022

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  2 in total

1.  Synthesis and contractile activity of substituted 1,2,3,4-tetrahydroisoquinolines.

Authors:  Iliyan Ivanov; Stoyanka Nikolova; Dimo Aladjov; Iliyana Stefanova; Plamen Zagorchev
Journal:  Molecules       Date:  2011-08-16       Impact factor: 4.411

2.  In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates.

Authors:  Angel J Ruiz-Moreno; Atilio Reyes-Romero; Alexander Dömling; Marco A Velasco-Velázquez
Journal:  Molecules       Date:  2021-03-26       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.